LianBio Cash and Cash Equivalents
LianBio (LIANY) had Cash and Cash Equivalents of $103.46 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2023-11-13
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $103.46M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $104.06M.
- 2023-03-31: Cash and Cash Equivalents, at Carrying Value $102.33M.
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $79.22M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2023-09-30 | $103.46M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $104.06M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $102.33M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $79.22M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $78.86M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $134.33M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $139.86M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $228.18M 10-K · filed 2023-03-28 |
| 2021-09-30 | $109.02M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $142.62M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $235.27M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $254.35M 10-K · filed 2022-03-31 |
| 2020-09-30 | $8.58M 10-Q/A · filed 2022-01-10 |